- Pfizer plans on sweetening offer for obesity drugmaker Metsera, source says Reuters
- Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera Barron’s
- FTC warns Novo that current Metsera offer structure may violate US merger law Fierce Biotech
- Exclusive | Pfizer Preps Improved Offer in Metsera Bidding War The Wall Street Journal
- Pfizer’s view on the Metsera bidding war statnews.com





